Barclays »

Bolt Biotherapeutics shares owned by Barclays

Quarter-by-quarter ownership of Bolt Biotherapeutics (BOLT) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Bolt Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bolt Biotherapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bolt Biotherapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $31 6 5.33
2025-06-30 $0 6 0.00

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Bolt Biotherapeutics

Vivo Capital
Sofinnova Ventures
Pivotal bioVenture Partners Investment Advisor
Tang Capital Management
Nan Fung Group Holdings
Samsara BioCapital
Board of Trustees of The Leland Stanford Junior University
Vanguard Group
Pfizer
Renaissance Technologies
Geode Capital Management
Susquehanna International
Shay Capital
Squarepoint Ops
DRW Holdings

View all funds holding Bolt Biotherapeutics